Facebook
Twitter
LinkedIn
ForwardModern Management of VTE [CME] (CONG2014-39)
This course includes the following:
Thrombosis Basic Science and Anticoagulants
Gary Raskob, PhD
Prevention and Prophylaxis
Joseph Caprini, MD, MS, FACS, RVT
SVT Beyond CALISTO: Practical Guidelines
Sherry Scovell-Fitch, MD
Treatment Duration: Role of Residual Thrombosis and D-Dimer
Gary Raskob, PhD
Calf Vein DVT
Fedor Lurie, MD, PhD
Pharmacomechanical Treatment of Acute DVT
Robert Worthington-Kirsch, MD, FSIR, FCIRSE, FACPh, RVT, RPVI
Question and Answer
All Faculty
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Participants must score 80% or greater on the Post-Test to advance and receive credit. They are given three attempts to meet this threshold.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
Target Audience
The content of this activity is designed to meet the needs of the following target audience: phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.
Learning Objectives
As a result of this activity the participant should be able to:
- Describe the use of the Caprini score to select thombosis prophylaxis.
- Determine which patients require ongoing prophylaxis following hospital discharge.
- Appropriately modify decision-making and referral patterns when confronted with a patient with proximal DVT.
- Identify the consequences of untreated or undertreated proximal DVT.
- Describe the general categories of new anticoagulants based on their target mechanism of action.
- Describe which new anticoagulants have been approved for the treatment of VTE.
- Summarize the medical and procedural/surgical treatments available to treat SVT.
| NAME | ROLE | COMMERCIAL INTEREST | TYPE OF RELATIONSHIP |
|---|---|---|---|
| Joseph Caprini, MD, MS, FACS, RVT | Moderator; Speaker | Pfizer Sanofi Poland | Consultant Speaker |
| Yung-Wei Chi, DO, FAHA, FSVM | Planner | None | n/a |
| Stephanie M. Dentoni, MD | Content Reviewer | None | n/a |
| Michael M. Di Iorio, MD, RPVI, RPhS | Content Reviewer | None | n/a |
| Phillip A. Hertzman, MD, FACP, FAAFP, FACPh | Content Reviewer | None | n/a |
| Fedor Lurie, MD, PhD | Speaker | Tactile Medical Technology Intervene | Principal Investigator Board Member |
| Michelle McEvoy, RN, MSN/Ed | Content Reviewer | None | n/a |
| Stephen H. Moss | Staff | None | n/a |
| Eric Mowatt-Larssen, MD, FACPh, RPhS | Content Reviewer | None | n/a |
| Gary Raskob, PhD | Speaker | Daiichi Sankyo BMS Bayer Healthcare Janssen Pharmaceuticals Pfizer Johnson and Johnson | Consultant Consultant Consultant Consultant Consultant Consultant |
| Sherry Scovell-Fitch, MD | Speaker | None | n/a |
| Saundra Spruiell, DO, FACPh, RPVI | Planner | None | n/a |
| Mary Emily Wilcox Cummings, MD | Content Reviewer | None | n/a |
| Robert Worthington-Kirsch, MD, FSIR, FCIRSE, FACPh, RVT, RPVI | Speaker | None | n/a |
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Review & Recertification
This course was reviewed and recertified for AMA PRA Category 1 CreditTM in February 2017.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Attendance